Alcoholic liver disease (ALD) comprises a clinical-histologic spectrum including fatty liver,
alcoholic hepatitis (AH), and cirrhosis with its complications. Most patients are diagnosed at …

Importance Alcohol-associated liver disease results in cirrhosis in approximately 10% to 20%
of patients. In 2017, more than 2 million people had alcohol-associated cirrhosis in the US. …

Bioenergetics has become central to our understanding of pathological mechanisms, the
development of new therapeutic strategies and as a biomarker for disease progression in …

Background In the background of availability of better treatments for specific liver diseases
and listing of nonalcoholic steatohepatitis (NASH) as an etiology for liver transplantation (LT), …

Oxidative stress is commonly associated with a number of liver diseases and is thought to
play a role in the pathogenesis of chronic hepatitis C , alcoholic liver disease, non‐alcoholic …

The Coronavirus Disease 2019 (COVID‐19) pandemic has exacted a heavy toll on patients
with alcohol‐associated liver disease (ALD) and alcohol use disorder (AUD). The collective …

BACKGROUND & AIMS: The effects of antiviral therapy on prevention of hepatocellular
carcinoma (HCC) in patients with hepatitis C virus (HCV)-related cirrhosis are unclear. We …

Hepatocellular carcinoma (HCC) is a leading cause of liver-related death worldwide. Hepatitis
C virus (HCV) infection is a major cause of advanced hepatic fibrosis and cirrhosis, with …

The prevalence of mesenteric venous thrombosis has increased over the past 2 decades
with the routine use of contrast-enhanced computed tomography (CT) in patients presenting …

Background & Aims Severe alcoholic hepatitis (AH) has high mortality. We assessed the
comparative effectiveness of pharmacological interventions for severe AH, through a network …